Drug intelligence / Profile preview

perinatal tissue-derived stem cells

Development stage
Unknown
Lead developer
Beijing Boya Research Institution
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intramuscular, Subcutaneous, Intrathecal, Intraarticular, Intradiscal, Intranasal, Inhalation, Ophthalmic, Intracoronary
01

Overview

Perinatal tissue-derived stem cells are a cell therapy product consisting of mesenchymal stem cells (MSCs) isolated from perinatal tissues, specifically the placenta and umbilical cord. Developed by Beijing Boya Research Institution (Boyalife Pharma), these cells are being investigated for their regenerative and immunomodulatory potential. The therapeutic approach leverages the ability of MSCs to home to sites of injury, secrete bioactive molecules that promote tissue repair, and modulate immune system activity to treat inflammatory and degenerative conditions. The clinical pipeline includes applications for premature aging (progeria), osteoarthritis, premature ovarian failure, systemic lupus erythematosus, and scleroderma, as well as cosmetic anti-aging treatments.

Other names
围产组织来源干细胞placenta-derived mesenchymal stem cellsumbilical cord-derived mesenchymal stem cellsperinatal mesenchymal stem cells

Beyond the preview

Go deeper on perinatal tissue-derived stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perinatal tissue-derived stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call